FIELD: experimental medicine, oncology.
SUBSTANCE: the present innovation deals with increasing body resistance, at carrying out anti-tumor chemotherapy, as well. For this purpose one should sample about 0.7-1.0 ml venous blood, phylgrastim at the dosage of 10 mg/kg body weight should be incubated with this blood during 45 min at 37° C followed by reinfusion. The innovation provides total increase of body resistance due to stimulating the development of not neutrophilic leukocytes and monocytes only, but erythrocytes, as well, and decreasing the number of mast cells and reticular cells of stroma, and, moreover, it leads to decreased toxicity of anti-tumor chemopreparations.
EFFECT: higher efficiency.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
BREAST CANCER CHEMOTHERAPY PROCEDURE | 2008 |
|
RU2372917C1 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
METHOD FOR TREATING MAMMALIAN GLAND CARCINOMA | 1998 |
|
RU2158588C2 |
METHOD OF TREATMENT OF PATIENTS WITH BREAST CANCER | 1998 |
|
RU2145239C1 |
METHOD TO TREAT MAMMARY GLAND CANCER | 2000 |
|
RU2178294C2 |
ANTIBIOTIC THERAPY METHOD | 2001 |
|
RU2195294C1 |
METHOD FOR TREATING MALIGNANT TUMORS | 2001 |
|
RU2210390C2 |
METHOD FOR TREATMENT OF ABDOMINAL CAVITY PRIMARY AND METASTATIC TUMORS | 2003 |
|
RU2272655C2 |
METHOD OF NEOADJUVANT CHEMOTHERAPY OF MAMMARY GLAND CANCER | 2007 |
|
RU2338545C1 |
METHOD FOR TREATING THE CASES OF PAIN SYNDROME IN ONCOLOGICAL PATIENTS | 2002 |
|
RU2218187C2 |
Authors
Dates
2006-06-27—Published
2004-10-06—Filed